Composition
- Active ingredients
- CYTARABINE 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CYTARABINE 100MG/ML · InjectableANDA076512-001 · Prescription
- CYTARABINE 20MG/ML · InjectableANDA200915-001 · Prescription
- CYTARABINE 20MG/ML · InjectableANDA206190-001 · Discontinued
- CYTARABINE 2GM/VIAL · InjectableANDA211938-001 · Prescription
- CYTARABINE 20MG/ML · InjectableANDA200914-001 · Discontinued
- CYTARABINE 20MG/ML · InjectableANDA071868-001 · Prescription
- CYTARABINE 1GM/VIAL · InjectableANDA074245-001 · Prescription
- CYTARABINE 2GM/VIAL · InjectableANDA074245-002 · Prescription
- CYTARABINE 100MG/ML · InjectableANDA201784-001 · Prescription
- CYTARABINE 20MG/ML · InjectableANDA208485-001 · Prescription
- CYTARABINE 100MG/VIAL · InjectableANDA211937-001 · Prescription
- CYTARABINE 500MG/VIAL · InjectableANDA071249-001 · Discontinued
- CYTARABINE 20MG/ML · Injectable
At a glance
- Brand name
- Cytarabine
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Teva Parenteral
- Status
- Discontinued
- FDA approval
- 17 Jun 1969
- Application
- NDA016793-004